LOX and breast cancer: Thus, in breast cancer models, the crosslink between fibrosis-associated deposition of type I collagen and integrin β1 or lysyl oxidase (LOX), was described to create a growth-permissive microenvironment capable of reawakening DCCs, thus supporting proliferative metastatic growth (46, 175).